These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 8814058)

  • 61. Mizoribine versus mycophenolate mofetil or intravenous cyclophosphamide for induction treatment of active lupus nephritis.
    Feng X; Gu F; Chen W; Liu Y; Wei H; Liu L; Yin S; Da Z; Sun L
    Chin Med J (Engl); 2014; 127(21):3718-23. PubMed ID: 25382325
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Devic's syndrome and SLE: challenges in diagnosis and therapeutic possibilities based on two overlapping cases.
    Polgár A; Rózsa C; Müller V; Matolcsi J; Poór G; Kiss EV
    Autoimmun Rev; 2011 Jan; 10(3):171-4. PubMed ID: 20920613
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Association between low-dose pulsed intravenous cyclophosphamide therapy and amenorrhea in patients with systemic lupus erythematosus: a case-control study.
    Baba S; Katsumata Y; Kawaguchi Y; Gono T; Sugiura T; Kanno T; Hara M; Yamanaka H
    BMC Womens Health; 2011 Jun; 11():28. PubMed ID: 21663683
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Cyclophosphamide in combination with glucocorticoids for severe neuropsychiatric systemic lupus erythematosus: a retrospective, observational two-centre study.
    Fanouriakis A; Pamfil C; Sidiropoulos P; Damian L; Flestea A; Gusetu G; Rednic S; Bertsias G; Boumpas DT
    Lupus; 2016 May; 25(6):627-36. PubMed ID: 26692040
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Clinical outcomes in patients with systemic lupus erythematosus treated with belimumab in clinical practice settings: a retrospective analysis of results from the OBSErve study in Switzerland.
    von Kempis J; Duetsch S; Reuschling N; Villiger R; Villiger PM; Vallelian F; Schaer DJ; Mueller RB
    Swiss Med Wkly; 2019 Feb; 149():w20022. PubMed ID: 30852830
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Is initial C-reactive protein level associated with corticosteroid use in lupus erythematosus patients during a bacterial infection episode?
    Wang KC; Liu PH; Yu KH; Weng YM; Ng CJ; Chiu TF; Chen SY
    Immunol Lett; 2017 May; 185():84-89. PubMed ID: 28286229
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Cyclophosphamide type I hypersensitivity in systemic lupus erythematosus.
    Thong BY; Leong KP; Thumboo J; Koh ET; Tang CY
    Lupus; 2002; 11(2):127-9. PubMed ID: 11958577
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Emergence of manifestations of HIV infection in a case of systemic lupus erythematosus following treatment with IV cyclophosphamide.
    Hazarika I; Chakravarty BP; Dutta S; Mahanta N
    Clin Rheumatol; 2006 Feb; 25(1):98-100. PubMed ID: 16132163
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Low dosage use of cyclophosphamide improves the survival of patients with systemic lupus erythematosus.
    Hussenbocus YAAM; Jin Z; Pan W; Liu L; Wu M; Hu H; Ding X; Wei H; Zou Y; Qian X; Wang M; Wu J; Tao J; Tan J; Da Z; Zhang M; Li J; Feng X; Sun L
    Clin Rheumatol; 2022 Jul; 41(7):2043-2052. PubMed ID: 35230560
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Cumulative Corticosteroid Dose Over Fifty-Two Weeks in Patients With Systemic Lupus Erythematosus: Pooled Analyses From the Phase III Belimumab Trials.
    van Vollenhoven RF; Petri M; Wallace DJ; Roth DA; Molta CT; Hammer AE; Tang Y; Thompson A
    Arthritis Rheumatol; 2016 Sep; 68(9):2184-92. PubMed ID: 26992106
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Infection in Thai patients with systemic lupus erythematosus: a review of hospitalized patients.
    Wongchinsri J; Tantawichien T; Osiri M; Akkasilpa S; Deesomchok U
    J Med Assoc Thai; 2002 Jun; 85 Suppl 1():S34-9. PubMed ID: 12188433
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Prevalence of premature ovarian failure in patients with systemic lupus erythematosus.
    Mayorga J; Alpízar-Rodríguez D; Prieto-Padilla J; Romero-Díaz J; Cravioto MC
    Lupus; 2016 Jun; 25(7):675-83. PubMed ID: 26678443
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Recent Trends of Infectious Complications Following Heart Transplantation.
    Multani A; Moayedi Y; Puing A; Henricksen E; Garvert DW; Gomez CA; Tremblay-Gravel M; Bunce PE; Luikart H; Ross HJ; Khush KK; Montoya JG; Teuteberg JJ
    Transplantation; 2020 Oct; 104(10):e284-e294. PubMed ID: 32413012
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Invasive fungal infections in Argentine patients with systemic lupus erythematosus.
    Vinicki JP; Catalan Pellet S; Pappalardo C; Cruzat VC; Spinetto MA; Dubinsky D; Tiraboschi IN; Laborde HA; Nasswetter G
    Lupus; 2013 Aug; 22(9):892-8. PubMed ID: 23861029
    [TBL] [Abstract][Full Text] [Related]  

  • 75. SLE and infections.
    Zandman-Goddard G; Shoenfeld Y
    Clin Rev Allergy Immunol; 2003 Aug; 25(1):29-40. PubMed ID: 12794259
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Central nervous system infections in Filipino patients with systemic lupus erythematosus.
    Vargas PJ; King G; Navarra SV
    Int J Rheum Dis; 2009 Sep; 12(3):234-8. PubMed ID: 20374352
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Rituximab vs mycophenolate and vs cyclophosphamide pulses for induction therapy of active lupus nephritis: a clinical observational study.
    Moroni G; Raffiotta F; Trezzi B; Giglio E; Mezzina N; Del Papa N; Meroni P; Messa P; Sinico AR
    Rheumatology (Oxford); 2014 Sep; 53(9):1570-7. PubMed ID: 24505125
    [TBL] [Abstract][Full Text] [Related]  

  • 78. High-dose cyclophosphamide for severe systemic lupus erythematosus.
    Gladstone DE; Prestrud AA; Pradhan A; Styler MJ; Topolsky DL; Crilley PA; Hoch S; Huppert A; Brodsky I
    Lupus; 2002; 11(7):405-10. PubMed ID: 12195780
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Early response to immunosuppressive therapy predicts good renal outcome in lupus nephritis: lessons from long-term followup of patients in the Euro-Lupus Nephritis Trial.
    Houssiau FA; Vasconcelos C; D'Cruz D; Sebastiani GD; de Ramon Garrido E; Danieli MG; Abramovicz D; Blockmans D; Mathieu A; Direskeneli H; Galeazzi M; Gül A; Levy Y; Petera P; Popovic R; Petrovic R; Sinico RA; Cattaneo R; Font J; Depresseux G; Cosyns JP; Cervera R
    Arthritis Rheum; 2004 Dec; 50(12):3934-40. PubMed ID: 15593207
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Menstrual disorders in girls with systemic lupus erythematosus treated with cyclophosphamide.
    Gonzalez-Crespo MR; Gomez-Reino JJ; Merino R; Ciruelo E; Gomez-Reino FJ; Muley R; Garcia-Consuegra J; Pinillos V; Rodriguez-Valverde V
    Br J Rheumatol; 1995 Aug; 34(8):737-41. PubMed ID: 7551658
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.